By Edward Winnick

SAN FRANCISCO (GenomeWeb News) – On the final day of the JP Morgan Healthcare Conference, several molecular tools and diagnostics vendors revealed their plans for 2011.

Among the firms that presented, Affymetrix talked about the firm's efforts in cytogenetics, Celera talked about its assay pipeline and search for a partner, and Complete Genomics said it is about to introduce a new technology that will make its sequencing more accurate while lowering cost.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.